Delivery of intracellular-acting biologics in pro-apoptotic therapies. - Wikidata - awgldk - TriplyDB

Delivery of intracellular-acting biologics in pro-apoptotic therapies.

Delivery of intracellular-acting biologics in pro-apoptotic therapies.

http://www.wikidata.org/entity/Q36588920

about

Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9 Selective permeabilization of cervical cancer cells to an ionic DNA-binding cytotoxin by activation of P2Y receptors.Endosomolytic Nano-Polyplex Platform Technology for Cytosolic Peptide Delivery To Inhibit Pathological Vasoconstriction.Combinatorial optimization of PEG architecture and hydrophobic content improves ternary siRNA polyplex stability, pharmacokinetics, and potency in vivo.Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo 'Smart' nanoparticles as drug delivery systems for applications in tumor therapy.Bioengineered silk gene delivery system for nuclear targeting.A BODIPY-embedding miltefosine analog linked to cell-penetrating Tat(48-60) peptide favors intracellular delivery and visualization of the antiparasitic drug.Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery.Targeting superoxide dismutase to endothelial caveolae profoundly alleviates inflammation caused by endotoxin.

P2860

Q28389837-EFD1FCA0-A06E-4582-9393-F2D06550DA97 Q35621198-533411A0-4D25-4A87-9166-F99746239165 Q35787259-089B7ADB-4277-4A89-9F15-75FB4BA00B52 Q36331202-BA2BD7A0-A36A-4239-B548-FA0A70225DF2 Q37378292-B4685A8A-DDEC-4BA4-9689-E50DCEE39E92 Q38550886-1504520C-B1E7-42EC-90DA-02D6425ADCBC Q38989049-F6FB7D3B-2C4B-489E-8BAA-661FEE442C52 Q39032576-447D0827-7CE9-4133-A785-080ADC582693 Q42077942-39552B10-F096-4B42-BC95-EDE0492AE827 Q47240067-9F2938EE-8B0F-4C95-B09A-685FB5C2BE1C

P2860

Delivery of intracellular-acting biologics in pro-apoptotic therapies.

http://www.wikidata.org/entity/Q36588920

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Delivery of intracellular-acting biologics in pro-apoptotic therapies.

@ast

Delivery of intracellular-acting biologics in pro-apoptotic therapies.

@en

type

label

Delivery of intracellular-acting biologics in pro-apoptotic therapies.

@ast

Delivery of intracellular-acting biologics in pro-apoptotic therapies.

@en

prefLabel

Delivery of intracellular-acting biologics in pro-apoptotic therapies.

@ast

Delivery of intracellular-acting biologics in pro-apoptotic therapies.

@en

P1433

Q36588920-FEE0F4D3-F149-4837-A4D8-C9B0B4E71234

P1476

Q36588920-63570A8C-79A6-4E8B-9DD8-C2B7D80CEE31

P2093

Q36588920-54B5B6B2-701C-496A-8D97-71BB6AE08E8F

Q36588920-80E7C17F-DF1E-4E00-B5F8-B3C657E704BE

Q36588920-96F51088-529F-4B9B-A5B8-E29F80C35F70

Q36588920-DA185F47-F2A0-4E2E-AE69-61852ED504E4

P2860

Q36588920-00209AB4-E3C9-49AC-8E87-185013F0AC75

Q36588920-00D9223A-6FA2-4CD9-933E-91BCFD1C6618

Q36588920-021D5841-097E-416D-8F17-4223A84D42A2

Q36588920-021DC6E9-CE65-4690-AD2B-6B92D7A22157

Q36588920-02253A14-69E9-4A54-9A75-80B2B9638098

Q36588920-02580496-80CD-4331-9DFD-34AFF6578823

Q36588920-026CA950-6E50-48B9-8825-3397144046D4

Q36588920-052AB87A-1BFB-497C-8627-34AF2874E3B6

Q36588920-053CCF5C-7A34-4875-B5B1-6660EAE75EA6

Q36588920-06BCA737-36F7-4652-AEED-964FA67D8987

P304

Q36588920-9FFA3B00-2127-4CDF-A11E-A8AD46FD4BBE

P31

Q36588920-DDDF7AED-C36A-484D-B2D1-0164505A5D77

P356

Q36588920-19418EE8-328C-4CA5-8A2D-CC928234F54B

P433

Q36588920-51EA13F9-46CB-490E-A2DD-1CA55FE17D88

P478

Q36588920-9EA926E4-45EB-4396-9668-542D8D9FB4FB

P577

Q36588920-BA3A390C-9636-45D2-B7A6-61A48C4C64D5

P5875

Q36588920-F99BA4FE-5803-4052-9F1A-80C2004631A8

P698

Q36588920-AE937026-D719-4626-BE85-0A1922E2DF62

P921

Q36588920-5E95025A-6607-4AF3-BE12-DF7DD5C2815A

P932

Q36588920-B4C78767-6720-4BE8-856F-9D45AA3B1095

P356

138161211795049642

P1433

Current Pharmaceutical Design

P1476

Delivery of intracellular-acting biologics in pro-apoptotic therapies.

@en

P2093

Brian C Evans

http://www.w3.org/2001/XMLSchema#string

Chris E Nelson

http://www.w3.org/2001/XMLSchema#string

Craig L Duvall

http://www.w3.org/2001/XMLSchema#string

Hongmei Li

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Oncogenes and Cancer

Livin, a novel inhibitor of apoptosis protein family member

Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function

Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis

Caspases: the executioners of apoptosis

P304

293-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/138161211795049642

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50194912

http://www.w3.org/2001/XMLSchema#string

P698

21348831

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

3564970

http://www.w3.org/2001/XMLSchema#string